LRRK2 in Parkinson disease: challenges of clinical trials
One of the most common monogenic forms of Parkinson disease (PD) is caused by
mutations in the LRRK2 gene that encodes leucine-rich repeat kinase 2 (LRRK2). LRRK2 …
mutations in the LRRK2 gene that encodes leucine-rich repeat kinase 2 (LRRK2). LRRK2 …
[HTML][HTML] Glutamate-induced excitotoxicity in Parkinson's disease: The role of glial cells
L Iovino, ME Tremblay, L Civiero - Journal of pharmacological sciences, 2020 - Elsevier
Glutamate is the major excitatory neurotransmitter in the central nervous system. Glutamate
transmission efficiency depends on the correct functionality and expression of a plethora of …
transmission efficiency depends on the correct functionality and expression of a plethora of …
Mitochondrial ROS promotes susceptibility to infection via gasdermin D-mediated necroptosis
Although mutations in mitochondrial-associated genes are linked to inflammation and
susceptibility to infection, their mechanistic contributions to immune outcomes remain ill …
susceptibility to infection, their mechanistic contributions to immune outcomes remain ill …
Parkinson's disease
Parkinson's disease is a neurological disorder with evolving layers of complexity. It has long
been characterised by the classical motor features of parkinsonism associated with Lewy …
been characterised by the classical motor features of parkinsonism associated with Lewy …
[HTML][HTML] Monogenic Parkinson's disease: genotype, phenotype, pathophysiology, and genetic testing
Genes | Free Full-Text | Monogenic Parkinson’s Disease: Genotype, Phenotype,
Pathophysiology, and Genetic Testing Next Article in Journal enChIP-Seq Analyzer: A …
Pathophysiology, and Genetic Testing Next Article in Journal enChIP-Seq Analyzer: A …
[HTML][HTML] Parkinson's disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis
G DeMaagd, A Philip - Pharmacy and therapeutics, 2015 - ncbi.nlm.nih.gov
Parkinson’s Disease and Its Management - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search …
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search …
Functional variants in the LRRK2 gene confer shared effects on risk for Crohn's disease and Parkinson's disease
Crohn's disease (CD), a form of inflammatory bowel disease, has a higher prevalence in
Ashkenazi Jewish than in non-Jewish European populations. To define the role of …
Ashkenazi Jewish than in non-Jewish European populations. To define the role of …
Inflammatory bowel disease and Parkinson's disease: common pathophysiological links
HS Lee, E Lobbestael, S Vermeire, J Sabino, I Cleynen - Gut, 2021 - gut.bmj.com
Inflammatory bowel disease and Parkinson's disease are chronic progressive disorders that
mainly affect different organs: the gut and brain, respectively. Accumulating evidence has …
mainly affect different organs: the gut and brain, respectively. Accumulating evidence has …
Genetics in Parkinson disease: Mendelian versus non‐Mendelian inheritance
DG Hernandez, X Reed… - Journal of …, 2016 - Wiley Online Library
Parkinson's disease is a common, progressive neurodegenerative disorder, affecting 3% of
those older than 75 years of age. Clinically, Parkinson's disease (PD) is associated with …
those older than 75 years of age. Clinically, Parkinson's disease (PD) is associated with …
[HTML][HTML] Exploring the journey of emodin as a potential neuroprotective agent: novel therapeutic insights with molecular mechanism of action
Emodin is an anthraquinone derivative found in the roots and bark of a variety of plants,
molds, and lichens. Emodin has been used as a traditional medication for more than 2000 …
molds, and lichens. Emodin has been used as a traditional medication for more than 2000 …